Johnson & Johnson Provides Upbeat Booster Shot Update

The security boasts reasonably priced options at the moment

Deputy Editor
Sep 21, 2021 at 10:28 AM
facebook twitter linkedin


The shares of Johnson & Johnson (NYSE:JNJ) are up 0.7% to trade at $164.90 at last check, after the company said a second shot of its Covid-19 vaccine administered about two months after the first dose increases effectiveness against moderate to severe disease to 94%. Plus, the pharmaceutical concern added the booster shot increases antibody levels four to six times.

On the charts, Johnson & Johnson stock yesterday fell to a three-month low of $162.16, with pressure coming from the once-supportive 150-day moving average, which coincides with a recent ceiling that has formed at the $166 level. Year-over-year, though, the security is still up 14%.

An unwinding of pessimism in the options could boost the shares. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), JNJ's 10-day put/call volume ratio stands higher than 80% of readings in the past year. This means puts have been getting picked up at a quicker-than-usual clip in the last two weeks.

At the moment, JNJ options are reasonably priced. This is per Johnson & Johnson stock's  Schaeffer's Volatility Index (SVI) of 19%, which ranks in the 30th percentile of its annual range, implying that options players are pricing in relatively low volatility expectations.

 

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners